Chargement en cours...
CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine
We investigated CD25 expression in older (≥60 years) patients with new acute myelogenous leukemia treated with decitabine and plerixafor. Patients resistant to therapy or survival ≤1 year had significantly higher percentages of CD25(pos) myeloid blasts in baseline bone marrow. CD25(pos) patients had...
Enregistré dans:
| Publié dans: | Leuk Lymphoma |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5773411/ https://ncbi.nlm.nih.gov/pubmed/28718760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2017.1352089 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|